Total debt has held near $56M while equity shrank to $34.2M, lifting the debt-to-equity ratio from 0.56 to 1.65, which suggests leverage risk is rising as the equity cushion erodes.
Pulmonx Corporation (LUNG) balance sheet — 8-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 |
|---|
| Total Current Assets | 84.06M | 101.68M | 136.25M | 150.42M | 168.95M | 208M | 249.99M | 41.07M | 11.31M |
| Cash & Short-Term Investments | 52.69M | 70.01M | 101.48M | 117.1M | 141.14M | 180.04M | 231.79M | 28.35M | 4.12M |
| Cash Only | 52.69M | 70.01M | 70.91M | 83.55M | 101.74M | 148.48M | 231.79M | 14.77M | 4.12M |
| Short-Term Investments | 0 | 0 | 30.58M | 33.55M | 39.4M | 31.56M | 0 | 13.58M | 0 |
| Accounts Receivable | 12.01M | 12.07M | 13.79M | 13.02M | 9.28M | 6.92M | 4.57M | 6M | 3.42M |
| Days Sales Outstanding | 48.93 | 48.69 | 60.08 | 69.2 | 63.11 | 52.2 | 50.93 | 67.17 | 62.42 |
| Inventory | 15.44M | 15.85M | 16.91M | 16.74M | 14.56M | 16.29M | 10.74M | 5.61M | 3.32M |
| Days Inventory Outstanding | 291.2 | 247.6 | 283.37 | 340.97 | 385.29 | 464.89 | 339.99 | 201.2 | 157.01 |
| Other Current Assets | 3.92M | 3.76M | 1.39M | 741K | 521K | 578K | 377K | 666K | 125K |
| Total Non-Current Assets | 26.15M | 27.61M | 26.6M | 27.36M | 24.72M | 27.17M | 13.72M | 12.46M | 3.71M |
| Property, Plant & Equipment | 18.8M | 20.25M | 21.45M | 7.43M | 10.5M | 12.89M | 10.45M | 7.46M | 375K |
| Fixed Asset Turnover | 4.56x | 4.47x | 3.91x | 9.24x | 5.11x | 3.76x | 3.13x | 4.37x | 53.34x |
| Goodwill | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M | 2.33M |
| Intangible Assets | 0 | 700K | 0 | 31K | 154K | 277K | 400K | 524K | 647K |
| Long-Term Investments | 0 | 0 | 0 | 14.39M | 5.92M | 10.94M | 0 | 0 | 0 |
| Other Non-Current Assets | 5.02M | 4.33M | 2.82M | 3.17M | 5.81M | 731K | 536K | 2.14M | 350K |
| Total Assets | 110.21M | 129.29M | 162.85M | 177.78M | 193.68M | 235.17M | 263.71M | 53.53M | 15.01M |
| Asset Turnover | 0.75x | 0.70x | 0.51x | 0.39x | 0.28x | 0.21x | 0.12x | 0.61x | 1.33x |
| Asset Growth % | -83.37% | -20.61% | -8.4% | -8.21% | -17.65% | -10.82% | 392.61% | 256.58% | - |
| Total Current Liabilities | 20.74M | 20.06M | 24.44M | 23.16M | 18.49M | 17.55M | 12.53M | 14.16M | 8.07M |
| Accounts Payable | 4.51M | 3.9M | 3.83M | 1.5M | 1.76M | 1.58M | 1.47M | 2.68M | 1.29M |
| Days Payables Outstanding | 75.4 | 61.02 | 64.11 | 30.49 | 46.51 | 45.16 | 46.59 | 96.12 | 60.96 |
| Short-Term Debt | 1.49M | 1.32M | 3.18M | 2.15M | 90K | 91K | 2.24M | 0 | 0 |
| Deferred Revenue (Current) | 78K | 18K | 135K | 104K | 120K | 163K | 71K | 173K | 139K |
| Other Current Liabilities | 14.73M | 4.98M | 6.89M | 7.88M | 4.97M | 4.74M | 3.1M | 6.47M | 2.49M |
| Current Ratio | 4.05x | 5.07x | 5.58x | 6.50x | 9.14x | 11.85x | 19.96x | 2.90x | 1.40x |
| Quick Ratio | 3.31x | 4.28x | 4.88x | 5.77x | 8.35x | 10.92x | 19.10x | 2.50x | 0.99x |
| Cash Conversion Cycle | 264.73 | 235.27 | 279.33 | 379.68 | 401.9 | 471.92 | 344.32 | 172.25 | 158.47 |
| Total Non-Current Liabilities | 55.27M | 55.12M | 52.6M | 36.31M | 21.18M | 24.38M | 25.05M | 226.75M | 174.27M |
| Long-Term Debt | 54.86M | 36.99M | 34M | 35.09M | 17.23M | 17.32M | 17.37M | 220.3M | 33.6M |
| Capital Lease Obligations | 35.8M | 18.06M | 18.52M | 1.11M | 3.85M | 6.84M | 7.62M | 6.4M | 0 |
| Deferred Tax Liabilities | 274K | 69K | 87K | 114K | 94K | 37K | 62K | 43K | 48K |
| Other Non-Current Liabilities | 345K | 0 | 0 | 0 | 0 | 179K | 0 | 0 | 140.61M |
| Total Liabilities | 76.01M | 75.17M | 77.04M | 59.47M | 39.67M | 41.93M | 37.57M | 240.91M | 182.34M |
| Total Debt | 56.35M | 56.36M | 56.47M | 41.42M | 24.4M | 26.46M | 27.22M | 227.15M | 33.6M |
| Net Debt | 3.66M | -13.64M | -14.43M | -42.12M | -77.33M | -122.02M | -204.57M | 212.39M | 29.48M |
| Debt / Equity | 1.65x | 1.04x | 0.66x | 0.35x | 0.16x | 0.14x | 0.12x | - | - |
| Debt / EBITDA | -1.46x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.09x | - | - | - | - | - | - | - | - |
| Interest Coverage | -8.99x | -15.92x | -14.94x | -17.65x | -53.94x | -57.28x | -9.07x | -7.78x | -6.33x |
| Total Equity | 34.2M | 54.12M | 85.81M | 118.31M | 154.01M | 193.24M | 226.13M | -187.38M | -167.33M |
| Equity Growth % | -164.31% | -36.93% | -27.47% | -23.18% | -20.3% | -14.55% | 220.68% | -11.98% | - |
| Book Value per Share | 0.79 | 1.33 | 2.19 | 3.12 | 4.15 | 5.35 | 6.34 | -5.29 | -8.08 |
| Total Shareholders' Equity | 34.2M | 54.12M | 85.81M | 118.31M | 154.01M | 193.24M | 226.13M | -187.38M | -167.33M |
| Common Stock | 44K | 42K | 40K | 39K | 38K | 37K | 36K | 19K | 17K |
| Retained Earnings | -553.69M | -521.56M | -467.56M | -411.16M | -350.32M | -291.39M | -242.73M | -210.5M | -189.8M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.72M | 2.36M | 2.11M | 2.64M | 1.57M | 1.71M | 1.69M | 1.37M | 1.33M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying LUNG stock.
As of 2025, Pulmonx Corporation (LUNG) had total assets of $129.3M including $101.7M in current assets.
Pulmonx Corporation (LUNG) carries total debt of $56.4M, offset by $70.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Pulmonx Corporation (LUNG) has total shareholders' equity (book value) of $54.1M ($1.33 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Pulmonx Corporation (LUNG) reported a current ratio of 5.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Shrinking equity cushion against losses
Metrics are mathematically derived from official filings.
Equity Eroding Under Sustained Losses
Based on Pulmonx's reported balance sheet, total equity fell from $101.2M in 2024Q2 to $34.2M in 2026Q3, a decline of roughly 66% as the accumulated deficit grew to $553.7M over the same ten quarters.
The balance sheet is weakening rather than stabilizing, with equity compressing at a pace that broadly tracks the recurring operating losses reported in the income statement. Equity erosion is the dominant structural change, and the remaining book value leaves a thinner buffer against further losses than the headline asset base suggests. Investors should monitor whether the rate of erosion slows as losses narrow, since the supplied data does not yet show a clear inflection.
Flat Debt Load Amplifies Leverage Ratio
Total debt has held near $56M across all ten quarters, so the reported debt-to-equity ratio climbed from 0.56 to 1.65 largely because the equity denominator shrank rather than because borrowing increased.
Because the debt balance has been essentially static, the rising D/E ratio reflects a shrinking equity base instead of a change in financing strategy, making leverage a symptom of accumulated losses. The obligations are now large relative to the book value supporting them. The supplied data does not describe debt maturity or cost, so analysts should evaluate whether operating cash flows, which remain negative, can service this load over time.
Cash Cushion Thinning Against Burn
As reported in the financial statements, cash fell from $75.5M in 2025Q2 to $52.7M in 2026Q3, while the current ratio remains elevated near 4.05, a comfort measure set against a shrinking pool of cash.
The liquidity position appears adequate in a static sense, yet the downward trend in cash balances points to a finite runway if operating cash burn persists at the levels implied by the cash flow data. A high current ratio alongside falling cash suggests current assets are being consumed rather than replenished. Analysts should treat the current ratio as a lagging indicator and focus on cash runway relative to quarterly burn.
Asset-Light Base With Minimal PPE
Based on Pulmonx's reported figures, net PP&E of roughly $19M and goodwill of $2.3M represent a small share of total assets of $110.2M in 2026Q3, indicating an asset base dominated by current items.
The asset mix reflects a business model that does not require heavy physical reinvestment, limiting capital-intensity risk but also offering little tangible collateral. Goodwill is small, so impairment risk is limited relative to the total asset base. Value therefore appears to reside mainly in working capital and cash rather than in long-lived operating assets.
Headline Current Ratio Overstates Safety
According to recent SEC filings, the current ratio of 4.05 in 2026Q3 looks robust, yet it has fallen from 8.97 in 2024Q2 as cash declined, meaning the headline liquidity metric is weakening faster than its level suggests.
A current ratio above 4 can mask a deteriorating liquidity position when the numerator is being drawn down by ongoing operating losses. The ratio's decline from 8.97 signals that the cushion is compressing even while remaining numerically high. Investors should weigh this against the persistent cash burn and the accumulated deficit, which together indicate the company's ability to absorb further shocks depends on continued access to its existing cash balance.